Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
7.27
-0.04 (-0.55%)
Apr 29, 2026, 11:20 AM EDT - Market open
Kezar Life Sciences Employees
Kezar Life Sciences had 9 employees as of December 31, 2025. The number of employees decreased by 46 or -83.64% compared to the previous year.
Employees
9
Change (1Y)
-46
Growth (1Y)
-83.64%
Revenue / Employee
n/a
Profits / Employee
-$6,225,889
Market Cap
53.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 119 |
| BeyondSpring | 44 |
| PDS Biotechnology | 24 |
| MiNK Therapeutics | 23 |
| Entera Bio | 22 |
| iBio, Inc. | 20 |
| Instil Bio | 14 |
| Cingulate | 14 |
KZR News
- 4 weeks ago - Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Business Wire
- 6 weeks ago - Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences - Business Wire
- 3 months ago - Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis - Business Wire
- 5 months ago - Kezar Life Sciences Reports Third Quarter 2025 Financial Results - Business Wire
- 6 months ago - Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025 - Business Wire
- 6 months ago - Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives - Business Wire
- 8 months ago - Kezar Life Sciences to Participate in Two Upcoming Investor Conferences - Business Wire
- 9 months ago - Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire